Search Results
Bharat Biotech Founder Assures Safety Of Covaxin, Pins Hopes On Its New Nasal Vaccine
Bharat Biotech's Proposal For Covid-19 Nasal Vaccine Trials | Milan Sharma's Report | India Today
Bharat Biotech Enrols Over 25,000 Volunteers For Covaxin Phase 3 Trial
Bharat Biotech's COVID Vaccine Covaxin Gets Nod From CDSCO Panel For Emergency Use
Covid-19 mutants: Can create a product in 15 days, says Bharat Biotech's Krishnan Ella
"For Humans there is no back-up. For a virus there is no back-up." :Bharat Biotech CMD| Krishna Ella
Covid update: Covaxin phase 3 trial; China locks down Hebei; UK vaccine supply
How Covaxin Curbs New Strain When Efficacy Against Primary Strain Is Unknown?; Sambit Patra Responds
India's Vaccine Challenge | Reality Check
India Can Innovate, It’s Not A Copycat Country: Bharat Biotech MD Krishna Ella
Bharat Biotech's Covaxin Led to Enhanced Immune Responses | Lancet
Kiran Shaw Decoding India’s Covid Vaccines | Barkha Dutt | Mojo Story